← Search all jobs

Director, Oligonucleotide Manufacturing

Dyne Therapeutics

Waltham, MA · $200k–$240k a year · Posted October 26, 2026

We last confirmed this job open on October 30, 2026. Check the employer’s site to see if it is still taking applications.

Just laid off? Start here: a plan for the first weeks

See every open role at Dyne Therapeutics

More in Massachusetts job market · Pharmaceuticals & Biotech · Operations jobs

More roles at Dyne Therapeutics

Similar jobs

Where Waltham, MA ranks

Where Waltham, MA placed in our monthly rankings, month by month. Each month stays online at its own address.

How AI is used in this kind of work

AI use among industrial production managers is little observed so far. Measured exposure for industrial production managers: 1% (little observed).

Share of this job’s tasks that AI is already used for at work, from real usage. It is not a forecast of job loss, and a low number means no use seen yet. Source: Anthropic Economic Index.

Check how this applies to your own job

Skills this job asks for

Say which you have and which you want to build. We use it to match you to jobs like this one.

About the job

Company Overview:

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/ , and follow us on X , LinkedIn and Facebook .

Role Summary:

The Director, Oligonucleotide Manufacturing, is accountable for translating Dyne’s CMC and program strategy into integrated manufacturing plans for oligonucleotide payloads from late-stage clinical development through commercial launch. This role leads external manufacturing strategy and execution, including CDMO selection and governance, technology transfer, scale-up, capacity planning, supply continuity, and cost management. The Director establishes operational priorities, performance expectations, and risk-mitigation plans to deliver robust, scalable, compliant, and cost-effective manufacturing. Working across Research, Regulatory, Quality, Clinical, Finance, and other functions in a matrixed environment, the Director leads cross-functional decision-making, advises senior leadership on manufacturing strategy and investment tradeoffs, and strengthens Dyne’s internal CMC capabilities.

This role is based in Waltham, MA without the possibility of being a remote role.

Primary Responsibilities Include:

Translate CMC and program strategy into integrated oligonucleotide manufacturing plans, priorities, budgets, resource requirements, timelines, and risk-mitigation actions for late-stage clinical and commercial supply

Lead oligonucleotide payload manufacturing from late-stage clinical development through commercial launch, setting and delivering against functional objectives, operational targets, and key milestones

Select, qualify, and govern external CDMOs, establishing performance expectations, operating standards, escalation pathways, and accountability for quality, compliance, cost, service, and delivery

Ensure uninterrupted clinical and commercial supply through long-range capacity planning, demand and supply alignment, scenario planning, and proactive mitigation of continuity risks

Provide financial stewardship for external manufacturing activities by developing forecasts, managing spend, evaluating investment options, and recommending cost, capacity, and sourcing tradeoffs

Lead technology transfer, scale-up, process validation, process improvements, and timely resolution of complex manufacturing issues across external partners

Review and approve cGMP documentation, including technology transfer, process and analytical development and validation reports, qualification protocols and reports, validation master batch records, and campaign summary reports

Prepare and review CMC sections for global regulatory submissions, including INDs, IMPDs, and BLAs, and support responses to health authority questions and inspections

Lead cross-functional decision-making with Research, Regulatory, Quality, Clinical, Finance, and other stakeholders to define compliant, scientifically sound, and executable CMC strategies

Advise senior leadership on manufacturing strategy, partner performance, supply risk, capacity, investment needs, and technical or business tradeoffs

Build scalable internal CMC and manufacturing capabilities through resource planning, knowledge transfer, development of standards and processes, and coaching of employees and cross-functional partners

Evaluate and implement emerging technologies and external capabilities that improve product quality, process performance, scalability, and cost effectiveness

Prepare and deliver technical documentation, governance updates, publications, and presentations for internal and external audiences

Education and Skills Requirements:

Advanced degree in Chemistry, Biochemistry, Chemical Engineering, Pharmaceutical Sciences, or a related discipline

10+ years of progressive experience in oligonucleotide manufacturing and CMC, including hands-on experience with oligonucleotide payloads, oligonucleotide-based therapeutics, and conjugates

Demonstrated experience translating program or CMC strategy into functional manufacturing plans, priorities, budgets, timelines, and risk-mitigation actions

Significant experience selecting, governing, and influencing CDMOs, with accountability for cGMP performance, quality, compliance, cost, and supply outcomes

Experience leading technology transfer, scale-up, validation, and late-stage clinical manufacturing; commercial launch experience preferred

Strong business and financial acumen, including experience with forecasting, external manufacturing spend, resource planning, and investment tradeoffs

Demonstrated ability to lead complex cross-functional work, reconcile competing priorities, and influence decisions without direct authority

Experience establishing governance, operating standards, and scalable processes and building capability through coaching, knowledge transfer, or team development

Strong knowledge of pharmaceutical and biotechnology industry trends, product development and life cycle management, global regulatory requirements, and clinical-stage manufacturing

Strong judgment, facilitation, negotiation, and problem-solving skills, with the ability to make and communicate recommendations on complex technical and business matters

Excellent verbal, written, and presentation skills, including the ability to communicate effectively with senior leaders, cross-functional teams, regulators, contractors, and external partners

Ability to operate independently, lead in a matrixed environment, and adapt priorities as business and program needs evolve

#LI-Onsite MA Pay Range $200,000 — $240,000 USD

The pay range reflects the base pay range Dyne reasonably expects to pay for this role at the time of posting. Individual compensation depends on factors such as education, experience, job-related knowledge, and demonstrated skills.

The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.

Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.